NL-OMON29530
Not yet recruiting
Not Applicable
A randomized, double blind, cross-over trial to study the effects of addingbezafibrate to standard lipid lowering therapy on postprandial lipids inpatients with familial dysbetalipoproteinemia
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Familial Dysbetalipoproteinemia Familiaire Dysbetalipoproteinemie (dutch)
- Sponsor
- niversity Medical Center Utrecht
- Enrollment
- 20
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Presence of a genetically confirmed apolipoprotein E2 homozygote
- •genotype or an autosomal dominant FD genotype in combination with (at
- •least) one of the following clinical characteristics:
Exclusion Criteria
- •o Use of any type of fibrate (including but not limited to gemfibrozil,
- •bezafibrate, fenofibrate and ciprofibrate);
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 4
A randomized, double blind, cross-over trial to study the effects of adding bezafibrate to standard lipid lowering therapy on postprandial lipids in patients with Familial Dysbetalipoproteinemia <br>Familial DysbetalipoproteinemiaFredrickson Type III hyperlipoproteinemia10013317NL-OMON43954Academisch Medisch Centrum15
Completed
Phase 2
A randomized, double-blind and cross-over trial to examine effects of continuous administration of intranasal oxytocin on social dysfunction in subjects with autism spectrum disordersAutism spectrum disordersJPRN-UMIN000007122Department of Neuropsychiatry, Graduate School of Medicine, University of Tokyo20
Active, not recruiting
Not Applicable
A trial comparing the safety and efficacy of insulin degludec and insulin glargine, both with insulin aspart as mealtime insulin in subjects with type 1 diabetesDiabetes Mellitus, Type 1MedDRA version: 17.0Level: LLTClassification code 10045228Term: Type I diabetes mellitusSystem Organ Class: 100000004861Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]EUCTR2012-001930-32-PLovo Nordisk A/S446
Active, not recruiting
Not Applicable
Double blind randomised cross-over trial to assess the value of screening an adult population for hypothyroidism - CROSS OVER RANDOMISED TRIAL OF ADULT HYPOTHROIDISM SCREENINGEUCTR2005-003464-30-GBQueen Mary, University of London
Completed
Phase 4
A randomized double blind cross-over trial of the effects of low dose and high dose hydrocortisone replacement therapy on cognition, quality of life, metabolic profile and somatosensation in patients with secondary adrenal insufficiencyadrenal insufficiencysecondary adrenal insufficiency10021112NL-OMON38411niversitair Medisch Centrum Groningen63